31P magnetic resonance spectroscopy as a predictor of efficacy in photodynamic therapy using differently charged zinc phthalocyanines
1999

Predicting the Effectiveness of Photodynamic Therapy with Zinc Phthalocyanines

publication Evidence: moderate

Author Information

Author(s): Bremner J C M, Wood S R, Bradley J K, Griffiths J, Adams G E, Brown S B

Primary Institution: MRC Radiobiology Unit, Chilton, Didcot, UK

Hypothesis

Can magnetic resonance spectroscopy measurements during photodynamic therapy predict its efficacy?

Conclusion

The study found a relationship between magnetic resonance spectroscopy measurements during photodynamic therapy and the ultimate effect on tumor regrowth.

Supporting Evidence

  • MRS measurements during PDT can predict the treatment's effectiveness.
  • Greater tumor regrowth delay was observed with a 1-hour interval between drug and light administration.
  • The order of tumor regrowth delay was PPC > TDEPC = TCPC.
  • Phosphate metabolism effects were greater with a 1-hour than a 24-hour interval.
  • Blood flow reduction is an important factor in PDT with these sensitizers.

Takeaway

This study looked at how a special type of therapy for tumors works better when certain conditions are met, and it found that measuring certain things during the treatment can help predict how well it will work.

Methodology

The study used a mouse model to assess tumor regrowth delay and phosphate metabolism through magnetic resonance spectroscopy.

Limitations

Data at the 24-hour interval were not statistically significant.

Participant Demographics

Mouse model bearing the RIF-1 murine fibrosarcoma line.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690738

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication